Hu14.18 (K322A)
Hu14.18 (K322A) is a humanized anti-disialoganglioside GD2 monoclonal antibody that contains fully human amino acid sequences for immunoglobulin G1 heavy and kappa light chains. hu14.18 (K322A) has antibody-dependent cellular cytotoxicity (ADCC) . hu14.18 (K322A) can be used for the study of high-risk neuroblastoma[1].
Product Specifications
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hu14-18-k322a.html
Purity
98.00
Smiles
[hu14.18(K322A)]
Molecular Weight
(144.76 kDa)
References & Citations
[1]Fariba Navid, et al. Phase I trial of a novel anti-GD2 monoclonal antibody, Hu14.18K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma. J Clin Oncol. 2014 May 10;32 (14) :1445-52.
Shipping Conditions
Dry Ice
Storage Conditions
-80°C
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
SIPJ894Hu01-01 10 µg
Recombinant Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca)
Request Quote
View Details SIPJ894Hu01-02 50 µg
Recombinant Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca)
Request Quote
View Details SIPJ894Hu01-03 200 µg
Recombinant Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca)
Request Quote
View Details 
SIPJ894Hu01-04 1 mg
Recombinant Phosphoinositide-3-Kinase Catalytic Alpha Polypeptide (PIK3Ca)
Request Quote
View Details